Minnesota Medical Cannabis Companies Find Relief in Pain
By John Schroyer
A new day has dawned for Minnesota’s medical marijuana industry.
The two companies licensed to cultivate and sell marijuana – LeafLine Labs and Minnesota Medical Solutions (MinnMed) – will benefit immensely from Wednesday’s decision to add intractable pain to the state’s list of qualifying medical conditions.
The move, announced by the state’s health commissioner, promises to catapult Minnesota’s sluggish market by helping boost the patient base significantly.
LeafLine Labs and MinnMed can now breathe a huge sigh of relief about the future – and potentially capture millions of additional dollars in sales annually.